Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ SLC16A3 Polyclonal Antibody

Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA5106683
Description
Antibody detects endogenous levels of total SLC16A3.
Lactic acid and pyruvate transport across plasma membranes is catalyzed by members of the proton-linked monocarboxylate transporter (MCT) family, which has been designated solute carrier family-16. Each MCT appears to have slightly different substrate and inhibitor specificities and transport kinetics, which are related to the metabolic requirements of the tissues in which it is found. The MCTs, which include MCT1 (SLC16A1; MIM 600682) and MCT2 (SLC16A7; MIM 603654), are characterized by 12 predicted transmembrane domains (Price et al., 1998 [PubMed 9425115]).
Specifications
| SLC16A3 | |
| Polyclonal | |
| Unconjugated | |
| SLC16A3 | |
| MCT 3; MCT 4; MCT3; MCT-3; Mct4; MCT-4; MGC138472; MGC138474; monocarboxylate transporter; monocarboxylate transporter 3; Monocarboxylate transporter 4; MOT4; Slc16a3; solute carrier family 16 (monocarboxylate transporter), member 3; solute carrier family 16 (monocarboxylic acid transporters), member 3; solute carrier family 16 member 3; solute carrier family 16, member 3 (monocarboxylic acid transporter 4) | |
| Rabbit | |
| Affinity chromatography | |
| RUO | |
| 80878, 80879, 9123 | |
| -20°C | |
| Liquid |
| Western Blot, Immunocytochemistry | |
| 1 mg/mL | |
| PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
| O15427, O35910, P57787 | |
| SLC16A3 | |
| A synthesized peptide derived from human SLC16A3(Accession O15427), corresponding to amino acid residues A232-G282. | |
| 100 μL | |
| Primary | |
| Human, Mouse, Rat | |
| Antibody | |
| IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction